NJOY Continues To Drive Altria Group’s (MO) Sustained Growth
Following a strong earnings report, Altria Group, Inc.'s stock price hit a 52-week high at $55.09.
Author Archive - Jabran Kundi
JD.com Inc. (JD) Stock Is A Risky Bet In The Current Market, Here’s Why
JD.com (JD) witnessed a drop in its stock on Thursday, despite reporting better-than-expected third-quarter earnings.
Risk And Reward Perfectly Aligned For Micron Technology Inc. (MU)
Micron stock is down 37% from its yearly highs and has been trading in a range for the last four months.
ServiceNow’s (NOW) Skyrocketing Valuation: Time For Investors To Cash Out?
ServiceNow stock (NOW) has been on a roll recently, boasting over 55% one-year returns, comfortably outpacing the S&P 500.
Stagwell Inc. (STGW) Is Putting All Eggs In The AI Basket, And Its Working!
Stagwell is pushing growth by leveraging AI and digital solutions through key acquisitions including BERA.AI and LEADERS.
Is BCE Inc.’s Dividend Storm Brewing?
BCE, Inc.'s recent financial struggles and questionable growth strategies are raising concerns about its ability to sustain dividends.
Guardant Health (GH) Set To Dominate The Growing Liquid Biopsy Market
Guardant Health, Inc.
Nio Inc.’s (NIO) Onvo Ramp: A Challenging Path With Promising Rewards
The Onvo marks another bold step for Nio toward an expanding lineup of electric models. However, the production ramp-up so far has fallen short of expectations.
Expedia’s (EXPE) ‘One Key’ Program Drives 60% Stock Surge, Here’s Why It Matters
Expedia's One Key loyalty program is a strategic initiative to drive future growth.
How Hewlett Packard’s (HPE) AI Drive Could Change The Game By 2026
The strategic acquisition of Juniper Networks by Hewlett Packard Enterprise presents the company with improved standing within global AI infrastructure.
Why AbbVie’s (ABBV) Drug Setback Creates A Prime Buy-The-Dip Moment
AbbVie stock fell 10% after emraclidine, its drug for schizophrenia, failed during the final stages of its trials.
Here’s How Jakafi’s Patent Expiry Impacts Incyte Corporation’s (INCY) Growth Prospects
Many investors continue to be worried about Incyte’s financial prospects when the patent for the company’s blood cancer medication, Jakafi, expires in 2028.
Ignore The Valuation And Buy The Growth In Intuitive Surgical (ISRG)
Intuitive Surgical (ISRG) is set to roll out its Da Vinci 5 robot in 2025. This positions the company well for significant growth in the coming years.
How Activist Investor Elliott’s Involvement Could Drive Honeywell’s (HON) Growth
Honeywell International stock has returned 25% in the last 5 years, a significant underperformance to the S&P 500 Industrials’ 76% return.
CHIPS Act Funding Strengthens Corning’s (GLW) Already Solid Fundamentals
Corning Incorporated (GLW) specializes in developing and manufacturing glass, ceramics, and optical physics products, serving diverse industries from telecommunications and consumer...
Margin Expansion Could Be Palo Alto Networks’ (PANW) Secret Weapon
A loosening monetary policy environment and Donald Trump’s victory have caused a lot of technology stocks to reach new highs.
HSBC Holding’s (HSBC) Strategic Overhaul Promises Better Returns
HSBC’s stock has seen a notable rise, fueled by its bold restructuring efforts and solid third-quarter performance, which have positioned the bank for continued growth.
Why Steven Madden (SHOO) Is An Uncertain Bet Amid Structural Changes
The recently announced Q3 financials of shoe and apparel company Steve Madden have surpassed Wall Street’s revenue expectations with a 13% YoY surge in sales driven by the growth...
Sony Group (SONY) Is Set To Soar, Here’s Why Investors Should Take Notice
Ever since the Sony Group reported a 36.5% surge in its net profit for the quarter ending September, it has been making headlines.
The Surprising Risks of DraftKings (DKNG), Why The House Doesn’t Always Win
DraftKings Inc.'s Q3 results reveal significant growth in customer acquisition, achieving a 39% YoY growth in revenue to $1,095 million.
How Trump’s Win Might Drive Foreign Defense Budgets, Benefiting Lockheed Martin (LMT)
Slowing revenue growth and reduced margins may have spoiled the party for Lockheed Martin (LMT) shareholders, but the stock has outperformed the S&P 500 this year.
Starbucks (SBUX) Fortunes Unlikely To Change In The Short Term
Starbucks (SBUX) has been expanding rapidly in China despite aggressively losing business in the country.
Why Johnson & Johnson (JNJ)’s Legal Issues Could Wrap Up Quickly
The first time Johnson & Johnson faced a lawsuit due to its talc-based baby powder causing cancer was way back in 1999.
No Guidance, Poor Result, And Management Shake Up Is Scaring Away Estee Lauder (EL) Investors
The recently announced financials of The Estee Lauder Companies Inc.
Two Major Factors Driving Costco’s (COST) Revenue Growth This Quarter
Costco stock is up nearly 200% in the last 5 years, and it is unlikely to slow down anytime soon.
Why Nike’s (NKE) 2025 Transformation Is The Buy Signal Investors Need
Nike Inc. has lost 55% of its market cap in the last three years.
JPMorgan’s (JPM) Strong Financials Likely To Sustain Strong Shareholder Returns
One look at JPMorgan’s 10-year stock price chart will tell you that its investors have reaped handsome rewards.
Navigating Uncertainties In McDonald’s Corporation (MCD): A Case For Selling
Mcdonald’s Corporation’s stock has been struggling since announcing the Q3 earnings report earlier this week.
Exxon Mobil (XOM) Finds Upside With Pioneer Merger, Defying Oil Price Slump
Exxon Mobil completed the acquisition of Pioneer Natural Resources in May this year.
Applied Materials (AMAT) Stock’s Underperformance Is A Buying Opportunity For Investors, Here’s Why
As the AI boom continues, investors are looking to invest in companies that offer the tools necessary to create AI products.
Investors Should Not Worry About Advanced Micro Devices’ (AMD) Lower Guidance, Here’s Why
AMD stock is tanking after its Q3 2024 earnings report. Investors aren't impressed by the weakness in non-AI segments as well as a lower-than-expected guidance.
Apple Intelligence Products Could Make Up For Apple’s (AAPL) iPhone Weakness
As smartphone companies fight to be the first to launch the latest generative AI features in their iPhones, Apple is taking its time.
Healthy Dividends Keep PepsiCo (PEP) Appealing Despite Limited Growth Prospects
PepsiCo Inc. isn't the hottest growth stock in the market right now and is unlikely to become one in the recent future.
Southwest Airlines (LUV) – Multiple Headwinds With No Clear Path To Destination
Southwest Airlines has always been a popular choice for US domestic travelers.
The Worst May Already Be Priced In For Lululemon (LULU) Stock
Not for the first time, Lululemon stock looks on track for a bull rally. The stock has been slowly going down by more than 50% from its all-time highs.
Is Bunge Global (BG) Stock Finally Ready For An Upside Break?
One look at the BG stock price history will tell you that, like many other companies, it enjoyed a post-COVID bull run. It seems to have stagnated since mid-2022 though.
Regulatory Issues And Soft Demand Continue To Weigh Down On CSX Corp (CSX) Stock
CSX Corp’s management is having a tough time dealing with soft demand and increasing debt.
International Revenue Growth Makes Medtronic (MDT) An Attractive Investment For Conservative Investors
Medtronic PLC investors have been content with receiving dividends on their holdings for a few years now.
GE Aerospace (GE) Stock Is Too High, Here’s Why You Should Be Cautious
GE Aerospace (GE) stock marches on despite multiple challenges including inflation, supply chain issues, and regulatory issues at Boeing.
Texas Instruments’ (TXN) Expansion Plans Position It As A Safe Semiconductor Investment
The third quarter of this year marks the first complete reporting period since activist investor Elliott Management took a $2.5 billion stake in the company.
Organic Growth and Margin Expansion Make Abbott Laboratories (ABT) A Solid Investment
Abbott Laboratories (ABT) stock has had negative returns for the last 3 years. But don't get fooled by that when analyzing the stock's performance.
Mobileye Stock’s (MBLY) Value Realization Could Take A Few More Years To Materialize
MobilEye stock is down 72% this year. This would scream a buy opportunity for any company with a decent potential.
How The Oncology Sector Is Set To Fuel AstraZeneca’s (AZN) Growth
AstraZeneca, a global biopharmaceutical company that develops and commercializes prescription medicines, became a household name during the Covid 19 pandemic thanks to its vaccines...
Philip Morris International’s (PM) Outperformance Likely To Continue Into Next Year, Here’s Why
Philip Morris International stock is up over 27% this year, despite a slump in the last month.
Aramark (ARMK) Stock: A Potential Arbitrage Could Send The Stock Skyrocketing
Aramark stock has had a good year so far, up over 40%. The company is riding recent industry trends. Some fundamental changes have set it up well for an extended bull run.
Here’s What It Will Take For Accenture (ACN) To Reach New All Time Highs
Nearly three years after hitting the $400 per share price mark, Accenture stock continues to trade sideways.
Marvell Technology’s (MRVL) Non-AI Revenue Could Positively Surprise Investors
Marvell Technology has jumped almost 50% since its August lows on the back of improving sales figures for the semiconductor industry.
Qualcomm (QCOM) Stock Dip Post Intel Acquisition Rumors Presents A Buying Opportunity
Qualcomm has been trying for months to break up the CPU market duopoly of Intel and AMD.
Buffett Could Miss Out On This Growth Driver After Selling Bank Of America (BAC) Stake
It's been more than three months since Warren Buffett started trimming down his stake in the Bank of America Corporation stock.
AT&T (T) Poised For A Bull Run As It Sheds Loss Making Media Business
After selling its 70% stake in DirecTV in a cash deal, AT&T is finally out of the media business.
